rxstat › Shortages › Idarubicin

Idarubicin shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Oct 1, 2026

A shortage of Idarubicin is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.

A chemotherapy drug used mainly to treat acute leukemia.

Products affected
0 / 1
Reports on file
9

Shortage history

2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Anticipated
IDARUBICIN
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02410028 · Disruption of the manufacture of the drug.
Anticipated
IDARUBICIN
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02410028 · Disruption of the manufacture of the drug.
Anticipated
IDARUBICIN
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02410028 · Disruption of the manufacture of the drug.
Resolved
IDARUBICIN
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02410028 · ended Jan 8, 2025 · Disruption of the manufacture of the drug.
Resolved
IDARUBICIN
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02410028 · ended May 14, 2025 · Disruption of the manufacture of the drug.
Resolved
IDARUBICIN
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02410028 · ended May 20, 2025 · Disruption of the manufacture of the drug.
Resolved
IDARUBICIN
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02410028 · ended Jan 12, 2024 · Disruption of the manufacture of the drug.
Resolved
IDARUBICIN
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02410028 · ended Dec 18, 2023 · Disruption of the manufacture of the drug.
Resolved
IDARUBICIN
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02410028 · ended Feb 10, 2023 · Disruption of the manufacture of the drug.

What's happening

A manufacturer has told Health Canada it expects supply of Idarubicin to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Idarubicin is classified under “CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES” (ATC L01DB).

Recent changes

Common questions

What is Idarubicin used for?

A chemotherapy drug used mainly to treat acute leukemia.

When will Idarubicin be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Idarubicin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (cytotoxic antibiotics and related substances)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Daunorubicin (Cerubidine) No current shortage Doxorubicin (Caelyx) Partial shortage 2 of 8 reported products affected Mitomycin Partial shortage 1 of 2 reported products affected Bleomycin Shortage anticipated 0 of 2 reported products affected Epirubicin Discontinued 0 of 3 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.